C10H21NO4
219.28 g/mol
APIWarning
Miglustat
CAS72599-27-0EC689-232-7
Category
API
Compound Class
Amine
Primary Use
Pharmaceutical Raw Material
Miglustat is a pharmaceutical raw material used as a glucosylceramide synthase inhibitor. It is supplied for manufacturing and research purposes in the pharmaceutical industry.
raw material for glucosylceramide synthase inhibitor productioncompound for research in lysosomal storage disorders
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 72599-27-0
Related Compounds
ReferenceSame Category
Dantrolene
CAS7261-97-4
pharmaceutical raw material
ReferenceSame Category
(−)-cathinone hydrochloride
CAS72739-14-1
pharmaceutical raw material
ReferenceSame Category
Benzododecinium bromide
CAS7281-04-1
pharmaceutical raw material
ReferenceSame Category
Neplanocin-a
CAS72877-50-0
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H332Harmful if inhaled
H335May cause respiratory irritation
H351Suspected of causing cancer
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
InChIKey
UQRORFVVSGFNRO-UTINFBMNSA-N
SMILES
CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O
Synonyms (35)
- NB-DNJ
- NBV
- OPFOLDA
- Miglustat (JAN/USAN/INN)
- 72599-27-0 (free base)
- Brazaves
- Brazaves (TN)
- BuDNJ
- Butyldeoxynojirimycin
- MIGLUSTAT [MART.]
- Miglustat
- N-(n-Butyl)deoxynojirimycin
- N-Bu-DNJ
- N-Butyl-DNJ
- N-Butyldeoxynojirimycin
- N-Butylmoranoline
- N-butyl-1-deoxynojirimycin
- Opfolda (TN)
- Vevesca
- Yargesa
- Zavesca
- Zavesca (TN)
- miglustatum